| Year |
Citation |
Score |
| 2020 |
Haedicke K, Agemy L, Omar M, Berezhnoi A, Roberts S, Longo-Machado C, Skubal M, Nagar K, Hsu HT, Kim K, Reiner T, Coleman J, Ntziachristos V, Scherz A, Grimm J. High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies. Nature Biomedical Engineering. 4: 286-297. PMID 32165736 DOI: 10.1038/S41551-020-0527-8 |
0.33 |
|
| 2019 |
Lebdai S, Gigoux M, Alvim R, Somma A, Nagar K, Azzouzi AR, Cussenot O, Merghoub T, Wolchok JD, Scherz A, Kim K, Coleman J. Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer. Oncoimmunology. 8: e1581528. PMID 31069149 DOI: 10.1080/2162402X.2019.1581528 |
0.377 |
|
| 2019 |
Corradi RB, LaRosa S, Jebiwott S, Murray KS, Rosenzweig B, Somma AJ, Gomez RS, Scherz A, Kim K, Coleman JA. Effectiveness of the combination of vascular targeted photodynamic therapy and anti-cytotoxic T-lymphocyte-associated antigen 4 in a preclinical mouse model of urothelial carcinoma. International Journal of Urology : Official Journal of the Japanese Urological Association. PMID 30659668 DOI: 10.1111/Iju.13878 |
0.303 |
|
| 2018 |
Neuschmelting V, Kim K, Malekzadeh-Najafabadi J, Jebiwott S, Prakash J, Scherz A, Coleman JA, Kircher MF, Ntziachristos V. WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice. Theranostics. 8: 723-734. PMID 29344301 DOI: 10.7150/Thno.20386 |
0.361 |
|
| 2018 |
Lee JS, Carmel N, Karathia H, Auslander N, Rabinovich S, Keshet R, Stettner N, Silberman A, Agemy L, Helbling D, Eilam R, Sun Q, Brandis A, Weiss H, Dimmock D, ... ... Scherz A, et al. Abstract A69: Mutagenicity of urea cycle dysregulation and its implications for cancer immunotherapy Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-A69 |
0.317 |
|
| 2018 |
Goldschmidt R, Koudinova N, Sasson K, Preise D, Agemy L, Mohan V, Bochner F, Sagi I, Neeman M, Scherz A. Vascular targeted photodynamic therapy for pancreatic ductal adenocarcinoma: A pre-clinical success Annals of Oncology. 29: iii21. DOI: 10.1093/Annonc/Mdy047.045 |
0.302 |
|
| 2018 |
Coleman J, Scherz A, Scardino P, Gill I, Lebdai S, Azzouzi AR, Emberton M. PD34-04 BIOPSY OUTCOMES AND PATTERNS OF PROSTATE CANCER GRADE PROGRESSION IN THE PCM301 RANDOMIZED TRIAL OF VASCULAR TARGETED PHOTODYNAMIC THERAPY AND ACTIVE SURVEILLANCE: IMPLICATIONS FOR FOCAL THERAPY Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1571 |
0.318 |
|
| 2017 |
Uzana R, Preise D, Agemy L, Elmualem R, Kelsen D, Gerdes H, Coleman J, Murray K, Belkin V, Sasson K, Yehezkel T, Salomon Y, Scherz A. A novel vascular targeted photodynamic therapy (VTP) in orthotopic rat model for the treatment of esophageal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: iii13-iii14. PMID 32135740 DOI: 10.1093/Annonc/Mdx261.002 |
0.321 |
|
| 2017 |
O'Shaughnessy MJ, Murray KS, La Rosa SP, Budhu S, Merghoub T, Somma A, Monette S, Kim K, Beluco Corradi R, Scherz A, Coleman J. Systemic antitumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28954788 DOI: 10.1158/1078-0432.Ccr-17-0186 |
0.306 |
|
| 2017 |
Cornelis FH, Kim K, Durack JC, Jebiwott S, Scherz A, Srimathveeravalli G, Coleman JA. Contrast enhanced ultrasound imaging can predict vascular-targeted photodynamic therapy induced tumor necrosis in small animals. Photodiagnosis and Photodynamic Therapy. PMID 28887222 DOI: 10.1016/J.Pdpdt.2017.09.002 |
0.355 |
|
| 2017 |
Filip-Granit N, Goldberg E, Samish I, Ashur I, van der Boom ME, Cohen H, Scherz A. Sub-Molecular Gates Self-Assemble for Hot Electron Transfer in Proteins. The Journal of Physical Chemistry. B. PMID 28498662 DOI: 10.1021/Acs.Jpcb.7B00432 |
0.564 |
|
| 2017 |
Kim K, Zhang H, LaRosa S, Jebiwott S, Desai P, Kimm SY, Scherz AJ, O'Donoghue JA, Weber WA, Coleman J. Bombesin Antagonist Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28108545 DOI: 10.1158/1078-0432.Ccr-16-2745 |
0.382 |
|
| 2017 |
Goldschmidt R, Vyacheslav K, Scherz A. Real time laser speckle imaging monitoring vascular targeted photodynamic therapy Proceedings of Spie. 10047. DOI: 10.1117/12.2251971 |
0.36 |
|
| 2017 |
Scherz A, Salomon Y, Coleman J. TOOKAD ® soluble VTP: From local tumor ablation to systemic cancer control Photodiagnosis and Photodynamic Therapy. 17: A22. DOI: 10.1016/J.Pdpdt.2017.01.049 |
0.302 |
|
| 2016 |
Kimm SY, Tarin TV, Monette S, Srimathveeravalli G, Gerber D, Durack JC, Solomon SB, Scardino PT, Scherz A, Coleman J. Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy. Radiology. 141571. PMID 26986047 DOI: 10.1148/Radiol.2016141571 |
0.313 |
|
| 2016 |
Preise D, Kudinova N, Lindner U, Sasson K, Uzana R, Coleman J, Salomon Y, Scherz A. Abstract B012: Immunomodulated VTP enables cure of metastatic prostate and breast cancers in animal models Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B012 |
0.367 |
|
| 2016 |
Kim K, Watson PA, Jebiwott S, Somma AJ, Rosa SPL, Mehta D, Murray KS, Lilja H, Ulmert D, Scherz A, Coleman J. Abstract 3389: Androgen deprivation therapy potentiates the efficacy of vascular targeted photodynamic therapy of prostate cancer xenografts Cancer Research. 76: 3389-3389. DOI: 10.1158/1538-7445.Am2016-3389 |
0.357 |
|
| 2016 |
Agemy L, Hamri R, Yechezkel T, Kudinova N, Salomon Y, Scherz A. 401P Enhancing antitumor immunity by photodynamic therapy with gemcitabine in metastatic 4T1 breast tumor. Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw588.007 |
0.309 |
|
| 2016 |
Lindner U, Preise D, Kudinova N, Agarounov A, Salomon Y, Coleman JA, Leibovici D, Scherz A. MP62-07 NEOADJUVANT IMMUNOMODULATION COMBINED WITH VASCULAR TARGETED THERAPY PREVENTS METASTASES AND IMPROVES SURVIVAL IN RATS WITH LOCALLY ADVANCED PROSTATE CANCER. Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.915 |
0.317 |
|
| 2015 |
Ben-Nun Y, Merquiol E, Brandis A, Turk B, Scherz A, Blum G. Photodynamic quenched cathepsin activity based probes for cancer detection and macrophage targeted therapy. Theranostics. 5: 847-62. PMID 26000057 DOI: 10.7150/Thno.10854 |
0.364 |
|
| 2015 |
Azzouzi AR, Barret E, Bennet J, Moore C, Taneja S, Muir G, Villers A, Coleman J, Allen C, Scherz A, Emberton M. TOOKAD(®) Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer. World Journal of Urology. 33: 945-53. PMID 25712310 DOI: 10.1007/S00345-015-1505-8 |
0.321 |
|
| 2015 |
O'Shaughnessy M, Murray KS, LaRosa S, Monette S, Kim K, Scherz A, Coleman JA. Systemic PD-1/PD-L1 inhibition combined with local vascular-targeted photodynamic therapy (VTP): Effects on primary tumor and prevention of lung metastasis in a preclinical RCC model. Journal of Clinical Oncology. 33: 477-477. DOI: 10.1200/Jco.2015.33.7_Suppl.477 |
0.306 |
|
| 2015 |
Uzana R, Preise D, Agemy L, Elmoalem R, Brandis A, Belkin V, Salomon Y, Scherz A. The treatment of esophageal cancer by vascular-targeted photodynamic therapy (VTP) using orthotopic rat model. Journal of Clinical Oncology. 33: 91-91. DOI: 10.1200/Jco.2015.33.3_Suppl.91 |
0.376 |
|
| 2015 |
O'Shaughnessy M, Murray K, LaRosa S, Monette S, Kim K, Beluco Corradi Fonseca R, Scherz A, Coleman J. PD33-03 TREATMENT OF THE PRIMARY TUMOR WITH VASCULAR-TARGETED PHOTODYNAMIC THERAPY (VTP) OVERCOMES RESISTANCE TO SYSTEMIC PD-1/PD-L1 INHIBITION: EFFECTS ON PRIMARY TUMOR CONTROL AND PREVENTION OF LUNG METASTASIS IN A PRE-CLINICAL RCC MODEL Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2101 |
0.314 |
|
| 2014 |
Winter A, Kimm S, Takaki H, Monette S, Scherz A, Coleman J. MP12-14 VASCULAR TARGETED PHOTODYNAMIC THERAPY IN THE SWINE URETER: TRANSMURAL ABLATION DOES NOT PRODUCE OBSTRUCTION IN THE SUBACUTE SETTING Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.449 |
0.305 |
|
| 2013 |
Chevalier S, Cury FL, Scarlata E, El-Zayat E, Hamel L, Rocha J, Zouanat FZ, Moussa S, Scherz A, Elhilali M, Anidjar M. Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model. The Journal of Urology. 190: 1946-53. PMID 23680311 DOI: 10.1016/J.Juro.2013.05.014 |
0.317 |
|
| 2013 |
Kimm S, Gerber D, Wimmer T, Srimathveeravalli S, Scherz A, Durack J, Solomon S, Coleman J. 1413 HISTOLOGIC CHARACTERIZATION AND COMPARISON OF ABLATIONS PRODUCED BY IRREVERSIBLE ELECTROPORATION, VASCULAR TARGETED PHOTODYNAMIC THERAPY, RADIOFREQUENCY ABLATION, AND CRYOTHERAPY: IMPLICATIONS FOR FOCAL THERAPY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2767 |
0.324 |
|
| 2012 |
Vilensky J, Koudinova NV, Harmelin A, Scherz A, Salomon Y. Vascular-targeted photodynamic therapy (VTP) of a canine-transmissible venereal tumour in a murine model with Pd-bacteriopheophorbide (WST09). Veterinary and Comparative Oncology. 3: 182-93. PMID 19754773 DOI: 10.1111/J.1476-5810.2005.00078.X |
0.317 |
|
| 2012 |
Tarin T, Kimm S, Zhao P, Trucco G, Scherz A, Coleman J. 1505 PHOTOTHERMAL EFFECT IN VASCULAR TARGETED PHOTODYNAMIC THERAPY Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1272 |
0.314 |
|
| 2011 |
Dinamarca J, Shlyk-Kerner O, Kaftan D, Goldberg E, Dulebo A, Gidekel M, Gutierrez A, Scherz A. Double mutation in photosystem II reaction centers and elevated CO2 grant thermotolerance to mesophilic cyanobacterium. Plos One. 6: e28389. PMID 22216094 DOI: 10.1371/Journal.Pone.0028389 |
0.551 |
|
| 2011 |
Chevalier S, Anidjar M, Scarlata E, Hamel L, Scherz A, Ficheux H, Borenstein N, Fiette L, Elhilali M. Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate. The Journal of Urology. 186: 302-9. PMID 21600602 DOI: 10.1016/J.Juro.2011.03.039 |
0.332 |
|
| 2011 |
Preise D, Scherz A, Salomon Y. Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP). Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 10: 681-8. PMID 21258718 DOI: 10.1039/C0Pp00315H |
0.388 |
|
| 2010 |
Goldshaid L, Rubinstein E, Brandis A, Segal D, Leshem N, Brenner O, Kalchenko V, Eren D, Yecheskel T, Salitra Y, Salomon Y, Scherz A. Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors. Breast Cancer Research : Bcr. 12: R29. PMID 20497549 DOI: 10.1186/Bcr2579 |
0.645 |
|
| 2010 |
Madar-Balakirski N, Tempel-Brami C, Kalchenko V, Brenner O, Varon D, Scherz A, Salomon Y. Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad. Plos One. 5: e10282. PMID 20421983 DOI: 10.1371/Journal.Pone.0010282 |
0.364 |
|
| 2010 |
Salomon Y, Goldshaid L, Glinert I, Brandis A, Scherz A. PL12 New applications of bacteriochlorophyll derivatives in photo-medicine: (1) Localization of necrotic breast tumors and (2) Photodynamic ablation of ectopic pregnancy Photodiagnosis and Photodynamic Therapy. 7: S4-S5. DOI: 10.1016/S1572-1000(10)70014-4 |
0.666 |
|
| 2009 |
Ashur I, Goldschmidt R, Pinkas I, Salomon Y, Szewczyk G, Sarna T, Scherz A. Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin. The Journal of Physical Chemistry. A. 113: 8027-37. PMID 19545111 DOI: 10.1021/Jp900580E |
0.329 |
|
| 2009 |
Davidson SR, Weersink RA, Haider MA, Gertner MR, Bogaards A, Giewercer D, Scherz A, Sherar MD, Elhilali M, Chin JL, Trachtenberg J, Wilson BC. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Physics in Medicine and Biology. 54: 2293-313. PMID 19305043 DOI: 10.1088/0031-9155/54/8/003 |
0.303 |
|
| 2009 |
Preise D, Oren R, Glinert I, Kalchenko V, Jung S, Scherz A, Salomon Y. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunology, Immunotherapy : Cii. 58: 71-84. PMID 18488222 DOI: 10.1007/S00262-008-0527-0 |
0.701 |
|
| 2008 |
Trachtenberg J, Weersink RA, Davidson SR, Haider MA, Bogaards A, Gertner MR, Evans A, Scherz A, Savard J, Chin JL, Wilson BC, Elhilali M. Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. Bju International. 102: 556-62. PMID 18494829 DOI: 10.1111/J.1464-410X.2008.07753.X |
0.301 |
|
| 2008 |
Fleshker S, Preise D, Kalchenko V, Scherz A, Salomon Y. Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate. Photochemistry and Photobiology. 84: 1231-7. PMID 18399928 DOI: 10.1111/J.1751-1097.2008.00340.X |
0.311 |
|
| 2008 |
Glinert IS, Geva E, Tempel-Brami C, Brandis A, Scherz A, Salomon Y. Photodynamic ablation of a selected rat embryo: a model for the treatment of extrauterine pregnancy. Human Reproduction (Oxford, England). 23: 1491-8. PMID 18287105 DOI: 10.1093/Humrep/Den039 |
0.655 |
|
| 2007 |
Trachtenberg J, Bogaards A, Weersink RA, Haider MA, Evans A, McCluskey SA, Scherz A, Gertner MR, Yue C, Appu S, Aprikian A, Savard J, Wilson BC, Elhilali M. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. The Journal of Urology. 178: 1974-9; discussion 1. PMID 17869307 DOI: 10.1016/J.Juro.2007.07.036 |
0.357 |
|
| 2005 |
Vakrat-Haglili Y, Weiner L, Brumfeld V, Brandis A, Salomon Y, McLlroy B, Wilson BC, Pawlak A, Rozanowska M, Sarna T, Scherz A. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. Journal of the American Chemical Society. 127: 6487-97. PMID 15853357 DOI: 10.1021/Ja046210J |
0.308 |
|
| 2005 |
Brandis A, Mazor O, Neumark E, Rosenbach-Belkin V, Salomon Y, Scherz A. Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins. Photochemistry and Photobiology. 81: 983-93. PMID 15839743 DOI: 10.1562/2004-12-01-Ra-389R1.1 |
0.308 |
|
| 2005 |
Mazor O, Brandis A, Plaks V, Neumark E, Rosenbach-Belkin V, Salomon Y, Scherz A. WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. Photochemistry and Photobiology. 81: 342-51. PMID 15623318 DOI: 10.1562/2004-06-14-Ra-199.1 |
0.317 |
|
| 2004 |
Plaks V, Koudinova N, Nevo U, Pinthus JH, Kanety H, Eshhar Z, Ramon J, Scherz A, Neeman M, Salomon Y. Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: A biphasic apparent diffusion coefficient change as potential early MRI response marker Neoplasia. 6: 224-233. PMID 15153334 DOI: 10.1593/Neo.3352 |
0.333 |
|
| 2004 |
Kelleher DK, Thews O, Scherz A, Salomon Y, Vaupel P. Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide. International Journal of Oncology. 24: 1505-11. PMID 15138594 DOI: 10.3892/Ijo.24.6.1505 |
0.366 |
|
| 2003 |
Preise D, Mazor O, Koudinova N, Liscovitch M, Scherz A, Salomon Y. Bypass of tumor drug resistance by antivascular therapy. Neoplasia (New York, N.Y.). 5: 475-80. PMID 14965440 DOI: 10.1016/S1476-5586(03)80031-3 |
0.323 |
|
| 2003 |
Gross S, Gilead A, Scherz A, Neeman M, Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI Nature Medicine. 9: 1327-1331. PMID 14502284 DOI: 10.1038/Nm940 |
0.354 |
|
| 2003 |
Koudinova NV, Pinthus JH, Brandis A, Brenner O, Bendel P, Ramon J, Eshhar Z, Scherz A, Salomon Y. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. International Journal of Cancer. 104: 782-9. PMID 12640688 DOI: 10.1002/Ijc.11002 |
0.372 |
|
| 2002 |
Chen Q, Huang Z, Luck D, Beckers J, Brun PH, Wilson BC, Scherz A, Salomon Y, Hetzel FW. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers. Photochemistry and Photobiology. 76: 438-45. PMID 12405153 DOI: 10.1562/0031-8655(2002)076<0438:Psincp>2.0.Co;2 |
0.302 |
|
| 2002 |
Yerushalmi R, Noy D, Baldridge KK, Scherz A. Mutual control of axial and equatorial ligands: model studies with [Ni]-bacteriochlorophyll-a. Journal of the American Chemical Society. 124: 8406-15. PMID 12105922 DOI: 10.1021/Ja0121078 |
0.564 |
|
| 2002 |
Schreiber S, Gross S, Brandis A, Harmelin A, Rosenbach-Belkin V, Scherz A, Salomon Y. Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery. International Journal of Cancer. 99: 279-85. PMID 11979445 DOI: 10.1002/Ijc.10299 |
0.341 |
|
| 2001 |
Zilberstein J, Schreiber S, Bloemers MC, Bendel P, Neeman M, Schechtman E, Kohen F, Scherz A, Salomon Y. Antivascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy. Photochemistry and Photobiology. 73: 257-266. PMID 11281022 DOI: 10.1562/0031-8655(2001)073<0257:Atosmt>2.0.Co;2 |
0.357 |
|
| 2000 |
Noy D, Yerushalmi R, Brumfeld V, Ashur I, Scheer H, Baldridge KK, Scherz A. Optical absorption and computational studies of [Ni]- bacteriochlorophyll-a. New insight into charge distribution between metal and ligands Journal of the American Chemical Society. 122: 3937-3944. DOI: 10.1021/Ja993761E |
0.57 |
|
| 1998 |
Noy D, Fiedor L, Hartwich G, Scheer H, Scherz A. Metal-substituted bacteriochlorophylls. 2. Changes in redox potentials and electronic transition energies are dominated by intramolecular electrostatic interactions Journal of the American Chemical Society. 120: 3684-3693. DOI: 10.1021/Ja970875M |
0.555 |
|
| 1998 |
Hartwich G, Fiedor L, Simonin I, Cmiel E, Schäfer W, Noy D, Scherz A, Scheer H. Metal-substituted bacteriochlorophylls. 1. Preparation and influence of metal and coordination on spectra Journal of the American Chemical Society. 120: 3675-3683. DOI: 10.1021/Ja970874U |
0.524 |
|
| 1998 |
Käß H, Lubitz W, Hartwig G, Scheer H, Noy D, Scherz A. ENDOR studies of substituted chlorophyll cation radicals Spectrochimica Acta - Part a: Molecular and Biomolecular Spectroscopy. 54: 1141-1156. DOI: 10.1016/S1386-1425(98)00065-1 |
0.552 |
|
| 1997 |
Zilberstein J, Bromberg A, Frantz A, Rosenbach-Belkin V, Kritzmann A, Pfefermann R, Salomon Y, Scherz A. Light-dependent Oxygen Consumption in Bacteriochlorophyll-Serine-treated Melanoma Tumors: On-line Determination Using a Tissue-inserted Oxygen Microsensor Photochemistry and Photobiology. 65: 1012-1019. PMID 9188281 DOI: 10.1111/J.1751-1097.1997.Tb07962.X |
0.317 |
|
| 1997 |
Teuchner K, Stiel H, Leupold D, Scherz A, Noy D, Simonin I, Hartwich G, Scheer H. Fluorescence and excited state absorption in modified pigments of bacterial photosynthesis: A comparative study of metal-substituted bacteriochlorophylls a Journal of Luminescence. 72: 612-614. DOI: 10.1016/S0022-2313(96)00411-5 |
0.571 |
|
| 1996 |
Rosenbach-Belkin V, Chen L, Fiedor L, Tregub I, Pavlotsky F, Brumfeld V, Salomon Y, Scherz A. Serine conjugates of chlorophyll and bacteriochlorophyll: Photocytotoxicity in vitro and tissue distribution in mice bearing melanoma tumors Photochemistry and Photobiology. 64: 174-181. PMID 8787011 DOI: 10.1111/J.1751-1097.1996.Tb02439.X |
0.303 |
|
| Show low-probability matches. |